What a phage display antibody library has to be before panning can work: why library diversity and phage display library construction quality decide the outcome more than the selection does, what a vhh library brings that a conventional fragment library does not, how phage display for antibody discovery compares with immunisation routes on time, epitope coverage and freedom to operate, what antigen production and antigen quality contribute to every campaign, where a vhh-fc or other fc fusion proteins format changes what you can screen for, and what bioconjugation and a dmpk antibody reagent add once a lead exists

Running a campaign

1. Judge the library on construction, not on a diversity number. A stated diversity is an upper bound. What matters is the fraction of clones in frame and expressing, the absence of dominant sequences, and how the library was amplified. Ask for the quality control data behind the number.
2. Make the antigen the way the target actually exists. A correctly folded, correctly modified antigen presented in a relevant format is what determines whether the binders you select recognise the real target. Denatured or truncated antigen selects binders to something that does not exist in vivo.
3. Design counter selection into every round. Selection enriches binders to the plate, the tag, the linker and the carrier as readily as to the antigen. Counter selection against those, and against a closely related protein where specificity matters, is the difference between hits and artefacts.
4. Screen at the format you intend to use. A fragment that binds well on phage may lose affinity or express poorly when reformatted. Reformatting early, even for a subset, avoids carrying leads that cannot become the molecule you need.
5. Sequence the output rather than picking clones blindly. Sequencing the enriched population reveals dominant families, convergence and whether selection actually worked. Picking colonies without it means rediscovering the same clone repeatedly and missing rare, better ones.
6. Check freedom to operate on the library and the format. Libraries, display systems and some formats carry commercial terms that follow the molecule. Establish them before a lead exists, because a lead you cannot license is a lead you cannot use.

Selection finds what you presented

The most reliable rule in display is that the campaign answers the question the selection conditions asked. Immobilisation chemistry, buffer, competitor and washing stringency together define that question, and changing any of them changes the binders that emerge.

Write the selection conditions down as a hypothesis about the molecule you want, and check them against the assay the leads will face. Divergence between the two is where campaigns quietly go wrong.

What happens after the hit

A binder becomes useful only once it is reformatted, expressed, purified and characterised for affinity, specificity, stability and developability. That work is a substantial project of its own and is frequently omitted from a discovery budget.

Plan it at the start, including the conjugation or fusion format the end use requires, so that leads are triaged against the properties that will actually matter rather than against affinity alone.

Common questions

Display or immunisation?

Display gives speed, control of the selection conditions and access to non immunogenic or toxic targets. Immunisation gives affinity matured binders and broader epitope coverage. Many programmes use both, and the choice depends on target and timeline rather than on principle.

Why did panning give binders that do not work in my assay?

Usually because the antigen presented during selection differed from the antigen in the assay, or because counter selection was inadequate. Selection is extremely good at finding whatever was actually there to bind.

How many rounds of selection?

Enough to enrich and not so many that a fast growing clone dominates. Monitoring enrichment between rounds and sequencing the population is more informative than a fixed number.

What should a discovery service deliver?

Sequences of the enriched families, the raw selection data, characterised binders in the intended format, and clear statements about library provenance and licence terms. A handful of clones with affinity values is not a campaign record.

Browse by service class

• Compare Gene synthesis on advertised prices